The need to change cervical cancer screening in the post-human papillomavirus vaccination era: the interplay between disease prevalence and risk, test characteristics, and efficiency of screening programs.

El-Zein M, Franco EL

Open source

DOI
10.1093/jncimonographs/lgag007
Published
2026 Aug 1
Container
Journal of the National Cancer Institute. Monographs
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jncimonographs/lgag007,
  title = {The need to change cervical cancer screening in the post-human papillomavirus vaccination era: the interplay between disease prevalence and risk, test characteristics, and efficiency of screening programs.},
  author = {El-Zein M and Franco EL},
  year = {2026},
  journal = {Journal of the National Cancer Institute. Monographs},
  doi = {10.1093/jncimonographs/lgag007},
  url = {https://doi.org/10.1093/jncimonographs/lgag007}
}

RIS

TY  - JOUR
TI  - The need to change cervical cancer screening in the post-human papillomavirus vaccination era: the interplay between disease prevalence and risk, test characteristics, and efficiency of screening programs.
AU  - El-Zein M
AU  - Franco EL
PY  - 2026
JO  - Journal of the National Cancer Institute. Monographs
DO  - 10.1093/jncimonographs/lgag007
UR  - https://doi.org/10.1093/jncimonographs/lgag007
ER  - 

APA

M, E., & EL, F. (2026). The need to change cervical cancer screening in the post-human papillomavirus vaccination era: the interplay between disease prevalence and risk, test characteristics, and efficiency of screening programs.. Journal of the National Cancer Institute. Monographs. https://doi.org/10.1093/jncimonographs/lgag007

Source records